Edition:
United Kingdom

Aurobindo Pharma Ltd (ARBN.NS)

ARBN.NS on National Stock Exchange of India

789.55INR
18 Apr 2019
Change (% chg)

Rs7.15 (+0.91%)
Prev Close
Rs782.40
Open
Rs785.00
Day's High
Rs794.00
Day's Low
Rs779.00
Volume
1,602,160
Avg. Vol
2,319,101
52-wk High
Rs830.45
52-wk Low
Rs527.00

About

Aurobindo Pharma Limited is a pharmaceutical company. The Company is engaged in producing oral and injectable generic formulations and active pharmaceutical ingredients (APIs). Its product portfolio is spread over seven therapeutic/product areas, including antibiotics, anti-retrovirals, cardiovascular, central nervous system,... (more)

Overall

Beta: 0.83
Market Cap(Mil.): Rs462,609.69
Shares Outstanding(Mil.): 585.92
Dividend: 1.25
Yield (%): 0.32

Financials

  ARBN.NS Industry Sector
P/E (TTM): 20.05 57.23 57.80
EPS (TTM): 39.38 -- --
ROI: -- 12.21 11.82
ROE: -- 13.15 12.64

Aurobindo Pharma to recall 80 lots of blood pressure medicine valsartan in the U.S.

A U.S. unit of Indian generic drugmaker Aurobindo Pharma Ltd will recall 80 lots of medicines containing blood pressure drug valsartan that were found to have a probable cancer-causing impurity, according to the U.S. Food and Drug Administration.

02 Jan 2019

India's Aurobindo Pharma Q2 profit falls nearly 22 pct

Nov 12 Aurobindo Pharma Ltd, India's second-largest drugmaker by market capitalisation, posted a 21.7 percent fall in its second-quarter profit on Monday, hurt by higher expenses, but beat analysts' estimates.

12 Nov 2018

Earnings vs. Estimates